AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.29X leverage
Performance
- Low
- ₹418
- High
- ₹428
- 52 Week Low
- ₹405
- 52 Week High
- ₹623
- Open Price₹421
- Previous Close₹421
- Volume81,267
- 50 DMA₹439.41
- 100 DMA₹453.45
- 200 DMA₹500.46
Investment Returns
- Over 1 Month -4.82%
- Over 3 Month -7.76%
- Over 6 Month -20.95%
- Over 1 Year -25.18%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 21.1
- PEG Ratio
- 1.5
- Market Cap Cr
- 6,686
- P/B Ratio
- 2.1
- Average True Range
- 11.04
- EPS
- 19.54
- Dividend Yield
- 0
- MACD Signal
- 0.09
- RSI
- 39.62
- MFI
- 30.85
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹424.80
+
4.3
(1.02%)
- Bearish Moving Average 15
- Bullish Moving Average 1
- 20 Day
- ₹435.74
- 50 Day
- ₹439.41
- 100 Day
- ₹453.45
- 200 Day
- ₹500.46
Resistance and Support
423.58
- R3 439.27
- R2 433.63
- R1 429.22
- S1 419.17
- S2 413.53
- S3 409.12
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results | |
| 2024-11-09 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹424 As on 26 January, 2026 | 05:03
The Market Cap of Akums Drugs & Pharmaceuticals is ₹6686.1 Cr As on 26 January, 2026 | 05:03
The P/E ratio of Akums Drugs & Pharmaceuticals is 21.1 As on 26 January, 2026 | 05:03
The PB ratio of Akums Drugs & Pharmaceuticals is 2.1 As on 26 January, 2026 | 05:03
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.